EUVIMED · CrossrefJournal
International Journal of Pharmaceutical Research and Allied Sciences
ISSN 2277-3657 · Polaris
Latest articles
Polygenic Pharmacotherapy beyond Single-Gene Rules: An Evidence Map of Scores, Interactions, Ancestry Transferability, and Clinical Utility
Cell-Free Pharmaceutical Biotechnology as a Modular Manufacturing Architecture for Rapid, Distributed, and Reconfigurable Therapeutic Production across Therapeutic Modalities
Do Comparative Efficacy Trials Still Resolve Meaningful Uncertainty in Biosimilar Development and Regulatory Decision-Making? A Critical Evidence Review
Self-Correcting Pharmaceutical Formulations That Sense Biological Conditions, Predict Performance Drift, and Adapt Drug Release across Changing Patient States
From Platform Readiness to Patient Readiness through a Decision Architecture for Next-Generation Pharmaceutical Translation under Scientific Uncertainty
Foundation Models for Pharmacoinformatics and QSAR: A Scoping Review of Transfer, Grounding, Calibration, and Chemical Validity
The Continually Learning QSAR System under Chemical-Space Drift, Endpoint Redefinition, Model Change, and Requalification throughout Deployment
Enhanced Sampling for Pharmaceutical Molecular Dynamics: A Systematic Review of Accuracy, Efficiency, Reproducibility, and Mechanistic Validity
Programmable Biomanufacturing Cells with Evidence-Bounded Control over Metabolic State, Product Quality, Yield, and Process Robustness across Manufacturing Scales
Counterfactual Dose Twins for Real-Time Precision Pharmacotherapy under Treatment Adaptation, Delayed Outcomes, Safety Constraints, and Incomplete Clinical Observation
High-Concentration Protein Formulations Under Injection Constraints: A Critical Review of Reversible Self-Association, Viscosity, Interfacial Damage, and the Trade-Off Between Dose Volume and Deliverability
Mechanistic Digital Twins of Drug–Target Dynamics for Counterfactual Perturbation, Adaptive Simulation, and Uncertainty-Aware Molecular Decision-Making
Delayed Safety Outcomes After Therapeutic Genome Editing: A Scoping Review of Clonal Dynamics, Genomic Alterations, Follow-Up Duration, and Adverse-Event Attribution in Clinical Translation
A Navigation Constitution for Autonomous Nanocarriers Crossing Biological Barriers under Uncertainty, Off-Target Risk, and Human Oversight
The Pharmaceutical Translation Observatory for Measuring How Laboratory Claims Become Reproducible, Manufacturable, and Patient-Relevant Evidence across Development Stages
Biosimilar Self-Administration as a Drug–Device–User System: A Conceptual Framework for Injection Mechanics, Handling Errors, and Delivered-Dose Consistency Across Presentation Changes
The Biological Afterlife of Nanocarriers: A Mass-Balance Framework for Connecting Material Degradation, Persistent Fragments, Repeat-Dose Accumulation, and Long-Term Pharmaceutical Safety
The Global Safety Knowledge Graph Linking Case Reports, Clinical Records, Scientific Literature, Regulatory Actions, and Product Changes
A Foundation Model for Pharmacokinetic and Pharmacodynamic Trajectories with Mechanistic Constraints, Missingness Awareness, and Calibrated Uncertainty
The Pharmacogenomic Digital Twin for Counterfactual Therapy Selection under Genotype, Phenoconversion, Polypharmacy, Disease Evolution, and Changing Treatment Goals
Synonymous Sequence Design in Therapeutic mRNA: A Mechanistic Framework for Balancing Transcript Stability, Translation Kinetics, Cotranslational Folding, and Functional Protein Production
Delivered Dose as an Emergent Property of Microneedle Formulations: A Coupled Mechanical–Pharmaceutical Framework for Skin Deformation, Insertion Heterogeneity, and Incomplete Matrix Dissolution
When Parent-Drug Exposure Misrepresents Pharmacological Burden: A Clinical Pharmacokinetic–Pharmacodynamic Framework for Active Metabolites, Opposing Activities, and Organ-Specific Toxicity
Living, Biohybrid, and Self-Propelled Drug Carriers: A Horizon Review of Programmable Targeting, Biological Navigation, and Translational Risk
FormulationGPT Is Not a Formulator: Governing Generative Artificial Intelligence across Excipient Selection, Process Design, and Product Decisions
Artificial Intelligence in Clinical Pharmacokinetics and Pharmacodynamics: A Realist Review of Contexts, Mechanisms, Outcomes, and Failure Modes
Whose Genome Guides the Prescription After Allogeneic Transplantation? A Tissue-of-Origin Framework for Pharmacogenomic Sampling, Donor–Recipient Chimerism, and Drug-Specific Interpretation
Adverse Events After Drug Discontinuation: A Pharmacovigilance Framework for Distinguishing Withdrawal Syndromes, Rebound Effects, Disease Recurrence, and Delayed Treatment-Related Harm
Antibiotic Dosing as an Evolutionary Intervention: A Pharmacokinetic–Pharmacodynamic Theory Linking Bacterial Killing, Resistant Subpopulation Amplification, and Post-Treatment Ecological Recovery
A Living Comparability Protocol for Biopharmaceutical Manufacturing Processes That Continuously Evolve without Losing Product Understanding across Product Lifecycles
EUVIMED